Paula Soteropoulos
Director at Dianthus Therapeutics, Inc. /DE/ (DNTH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 11SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 599 | $85.47 | $51K | -15.7% |
| Apr 1SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 599 | $80.11 | $48K | -10.0% |
| Mar 26SEC | DNTHDianthus Therapeutics, Inc. /DE/ | Sell Plan | 27,594 | $78.05 | $2.2M | -7.6% |
- Sell
Director Paula Soteropoulos sold $51K of DNTH at $85.47 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paula Soteropoulos sold $48K of DNTH at $80.11 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Paula Soteropoulos sold $2.2M of DNTH at $78.05 — pre-scheduled 10b5-1 plan sale.